MREO
Mereo BioPharma
MREO
MREO
77 hedge funds and large institutions have $435M invested in Mereo BioPharma in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 79 → 77 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
21% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 24
Holders
77
Holding in Top 10
3
Calls
$3.18M
Puts
$2.25M
Top Buyers
| 1 | +$18.4M | |
| 2 | +$9.01M | |
| 3 | +$8.8M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$2.86M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.4M |
Top Sellers
| 1 | -$8.53M | |
| 2 | -$3.19M | |
| 3 | -$2.05M | |
| 4 |
Renaissance Technologies
New York
|
-$1.88M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.87M |